Tetra Bio-Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Aug '22 Aug 31, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018	Nov '17 Nov 30, 2017
Net Income	-39.02	-52.18	-26.48	-15.28	-7.57	-6.23
Depreciation & Amortization	0.1	0.11	0.03	0.03	-	0.01
Loss (Gain) From Sale of Assets	-	-	-	-	-4.23	-
Asset Writedown & Restructuring Costs	23.98	23.98	0.4	-	-	-
Loss (Gain) From Sale of Investments	1.56	1.24	-	-	-	-
Loss (Gain) on Equity Investments	0.65	0.95	0.27	-	-	-
Stock-Based Compensation	0.26	1.05	0.57	0.23	1.43	2.31
Other Operating Activities	0.11	0.11	5.32	2.2	-0.27	-0.19
Change in Accounts Receivable	0.4	0.4	-0.36	0.47	-0.57	-0.13
Change in Inventory	-	-	-	-	0.04	-0.04
Change in Accounts Payable	3.9	-0.56	2.84	-0.79	2.04	0.35
Change in Other Net Operating Assets	-0.13	-0.38	-0.29	0.31	-0.39	0.03
Operating Cash Flow	-8.18	-25.28	-19.64	-17.34	-9.51	-3.89
Capital Expenditures	-0.01	-0.34	-0.24	-0.25	-	-
Cash Acquisitions	-	-	-	-3.43	-2.48	-
Divestitures	-	-	-	-	0.35	-
Sale (Purchase) of Intangibles	-0.02	-0.82	-1.91	-	-	-0.75
Investment in Securities	-0.65	-0.97	-1.26	-	-	-
Investing Cash Flow	-0.68	-2.12	-3.42	-3.69	-2.13	-0.75
Long-Term Debt Issued	-	3	-	-	-	-
Total Debt Issued	-	3	-	-	-	-
Short-Term Debt Repaid	-	-2	-	-	-	-
Total Debt Repaid	-1.45	-2	-	-	-	-
Net Debt Issued (Repaid)	-1.45	1	-	-	-	-
Issuance of Common Stock	2.63	31.45	27.04	8.61	24.63	5.62
Other Financing Activities	-0.4	-2.67	-3.52	1.12	-1.59	-0.01
Financing Cash Flow	0.78	29.78	23.52	9.73	23.03	5.62
Net Cash Flow	-8.09	2.39	0.46	-11.3	11.39	0.97
Free Cash Flow	-8.2	-25.61	-19.88	-17.6	-9.51	-3.89
Free Cash Flow Per Share	-0.02	-0.06	-0.08	-0.09	-0.07	-0.04
Levered Free Cash Flow	-3.52	-16.79	-11.26	-9.2	-4.71	-2.44
Unlevered Free Cash Flow	-3.21	-15.6	-11.26	-9.2	-4.71	-2.44
Change in Working Capital	4.17	-0.54	2.18	-0.01	1.14	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.